JPMorgan Chase & Co’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4M | Buy |
1,458,897
+467,579
| +47% | +$8.47M | ﹤0.01% | 1558 |
|
|
2025
Q1 | $20.3M | Buy |
991,318
+930,341
| +1,526% | +$19M | ﹤0.01% | 1696 |
|
|
2024
Q4 | $1.57M | Buy |
60,977
+38,626
| +173% | +$993K | ﹤0.01% | 3541 |
|
|
2024
Q3 | $371K | Buy |
22,351
+14,280
| +177% | +$237K | ﹤0.01% | 4186 |
|
|
2024
Q2 | $155K | Buy |
8,071
+3,752
| +87% | +$72.1K | ﹤0.01% | 4383 |
|
|
2024
Q1 | $102K | Buy |
+4,319
| New | +$102K | ﹤0.01% | 4726 |
|
|
2023
Q4 | – | Sell |
-2,622
| Closed | -$24.3K | – | 6642 |
|
|
2023
Q3 | $24.3K | Sell |
2,622
-8,841
| -77% | -$81.8K | ﹤0.01% | 5104 |
|
|
2023
Q2 | $136K | Sell |
11,463
-10,904
| -49% | -$130K | ﹤0.01% | 4487 |
|
|
2023
Q1 | $301K | Buy |
22,367
+21,265
| +1,930% | +$286K | ﹤0.01% | 4092 |
|
|
2022
Q4 | $12K | Buy |
+1,102
| New | +$12K | ﹤0.01% | 5074 |
|